ArticleRheumatology (Oxford, England)2024

Evaluation of serious infections, including Mycobacterium tuberculosis, during treatment with biologic disease-modifying anti-rheumatic drugs: does line of therapy matter?

Kim Lauper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.